About
VIAQUA addresses the growing need for effective and affordable health management solutions for aquaculture. VIAQUA’s 1st product is a novel oral delivery platform designed to deliver RNA. Co-developed with Skretting (a Nutreco company), RNA induced resistance to white Spot Shrimp Virus is incorporated into and delivered by shrimp-feed.
Tags
Total Employees
14
Current headcount
Score Breakdown
54Traction
47Team
60Visibility
25Profile
70Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ViAqua Therapeutics do?
VIAQUA addresses the growing need for effective and affordable health management solutions for aquaculture. VIAQUA’s 1st product is a novel oral delivery platform designed to deliver RNA. Co-developed with Skretting (a Nutreco company), RNA induced resistance to white Spot Shrimp Virus is incorporated into and delivered by shrimp-feed.
How much funding has ViAqua Therapeutics raised?
ViAqua Therapeutics has raised a total of $13M in funding. The most recent round on record is Series A.
When was ViAqua Therapeutics founded?
ViAqua Therapeutics was founded in 2014.
What industry does ViAqua Therapeutics operate in?
ViAqua Therapeutics operates in Aquaculture, Seafood, Disease Management, Biotech, Life Sciences, RNA.
How many employees does ViAqua Therapeutics have?
ViAqua Therapeutics has approximately 14 people on record.